Physician profile
Peter Saccone
NPI 1295066181
$149,382.74
in general payments reported to CMS, 2019-2025
43 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,975 · 2020: $8,071 · 2021: $36K · 2022: $27K · 2023: $36K · 2024: $22K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Food and Beverage: $9,011 · Travel and Lodging: $936 · Education: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,776.50 |
| Food and Beverage | $9,010.70 |
| Travel and Lodging | $935.97 |
| Education | $271.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $65,273.57 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $55,272.55 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Mylan Specialty L.P. | $16,198.94 | 2019-2024 | Yupelri, Yupelri |
| Viatris Specialty LLC | $3,833.67 | 2025 | Yupelri |
| Genzyme Corporation | $1,066.37 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $775.28 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $758.70 | 2019-2025 | Spiriva Respimat, Ofev, Jascayd |
| Philips North America LLC | $707.24 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und, Incourage Airway Clearance Therapy |
| Viiv Healthcare Company | $600.00 | 2019 | |
| Amgen INC. | $521.72 | 2021-2025 | Tezspire |
| Harmony Biosciences LLC | $506.56 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $407.03 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $405.96 | 2019-2025 | |
| Genentech USA, INC. | $380.15 | 2019-2025 | Xolair |
| Grifols USA, LLC | $332.51 | 2019-2025 | Prolastin-C Liquid |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $306.41 | 2023-2025 | Sunosi |
| Insmed, INC. | $213.30 | 2019-2024 | Arikayce |
| Mallinckrodt Hospital Products INC. | $187.47 | 2021-2025 | Acthar |
| Advanced Respiratory, INC | $174.93 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $151.91 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $134.98 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $130.42 | 2024-2025 | Lumryz |
| Verona Pharma, INC. | $121.37 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $120.71 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.31 | 2020-2025 | Aralast |
| Electromed, INC. | $96.90 | 2019-2025 | Smartvest |
| Baxter Healthcare | $95.53 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $87.20 | 2023-2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $80.01 | 2023-2025 | Inspire |
| Covis Pharma Gmbh | $40.59 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $33.62 | 2024 | Quviviq |
| Resmed Corp | $31.22 | 2023 | |
| Ucb, INC. | $29.41 | 2021 | |
| Merck Sharp & Dohme LLC | $29.31 | 2023-2024 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $27.50 | 2021-2023 | Uptravi, Opsumit |
| Shire North American Group INC | $26.98 | 2019 | |
| Phadia US INC. | $20.29 | 2023 | Immunocap |
| Circassia INC. | $17.99 | 2019 | |
| Inogen, INC. | $17.97 | 2025 | |
| Pulmonx Corporation | $16.84 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| United Therapeutics Corporation | $14.71 | 2023 | Tyvaso |
| Horizon Therapeutics Plc | $11.36 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Saccone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.